GLP-1 RECEPTOR AGONISTS HAVING IMPROVED PHARMACOLOGICAL AND DRUG DELIVERY PROPERTIES
Disclosed are polypeptides, compositions, and methods useful for activating a glucagon-like peptide- 1 (GLP-1) receptor and treating or preventing diseases or disorders at least partially mediated by glucagon-like peptide 1 (GLP-1). L'invention concerne des polypeptides, des compositions et des...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; fre |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | GRIBKOFF, Valentin DILLER, David SWANSON, Jon SHRIER, Allison PENTELUTE, Bradley SAWYER, Jonathon GUNASEKERA, Dinara SAWYER, Tomi AUDIE, Joseph SANTIAGO, Solimar |
description | Disclosed are polypeptides, compositions, and methods useful for activating a glucagon-like peptide- 1 (GLP-1) receptor and treating or preventing diseases or disorders at least partially mediated by glucagon-like peptide 1 (GLP-1).
L'invention concerne des polypeptides, des compositions et des méthodes utiles pour activer un récepteur de peptide-1 de type glucagon (GLP-1) et traiter ou prévenir des maladies ou des troubles au moins partiellement médiés par le peptide 1 de type glucagon (GLP-1). |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2022266068A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2022266068A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2022266068A23</originalsourceid><addsrcrecordid>eNqNyrEKwjAQANAuDqL-w4FzoUYorkdyJoE0Cdc04lSKxEm0UP8fHfwAp7e8dZW0i_UBmCTFFBhQB2_71IPBbL0G20UOmRREg9yhDC5oK9EBegWKBw2KnM3EV_jGSJws9dtqdZ8eS9n93FT7MyVp6jK_xrLM0608y3u8BNEIIdq2aU8ojv-tD_lGMT0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>GLP-1 RECEPTOR AGONISTS HAVING IMPROVED PHARMACOLOGICAL AND DRUG DELIVERY PROPERTIES</title><source>esp@cenet</source><creator>GRIBKOFF, Valentin ; DILLER, David ; SWANSON, Jon ; SHRIER, Allison ; PENTELUTE, Bradley ; SAWYER, Jonathon ; GUNASEKERA, Dinara ; SAWYER, Tomi ; AUDIE, Joseph ; SANTIAGO, Solimar</creator><creatorcontrib>GRIBKOFF, Valentin ; DILLER, David ; SWANSON, Jon ; SHRIER, Allison ; PENTELUTE, Bradley ; SAWYER, Jonathon ; GUNASEKERA, Dinara ; SAWYER, Tomi ; AUDIE, Joseph ; SANTIAGO, Solimar</creatorcontrib><description>Disclosed are polypeptides, compositions, and methods useful for activating a glucagon-like peptide- 1 (GLP-1) receptor and treating or preventing diseases or disorders at least partially mediated by glucagon-like peptide 1 (GLP-1).
L'invention concerne des polypeptides, des compositions et des méthodes utiles pour activer un récepteur de peptide-1 de type glucagon (GLP-1) et traiter ou prévenir des maladies ou des troubles au moins partiellement médiés par le peptide 1 de type glucagon (GLP-1).</description><language>eng ; fre</language><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221222&DB=EPODOC&CC=WO&NR=2022266068A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221222&DB=EPODOC&CC=WO&NR=2022266068A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GRIBKOFF, Valentin</creatorcontrib><creatorcontrib>DILLER, David</creatorcontrib><creatorcontrib>SWANSON, Jon</creatorcontrib><creatorcontrib>SHRIER, Allison</creatorcontrib><creatorcontrib>PENTELUTE, Bradley</creatorcontrib><creatorcontrib>SAWYER, Jonathon</creatorcontrib><creatorcontrib>GUNASEKERA, Dinara</creatorcontrib><creatorcontrib>SAWYER, Tomi</creatorcontrib><creatorcontrib>AUDIE, Joseph</creatorcontrib><creatorcontrib>SANTIAGO, Solimar</creatorcontrib><title>GLP-1 RECEPTOR AGONISTS HAVING IMPROVED PHARMACOLOGICAL AND DRUG DELIVERY PROPERTIES</title><description>Disclosed are polypeptides, compositions, and methods useful for activating a glucagon-like peptide- 1 (GLP-1) receptor and treating or preventing diseases or disorders at least partially mediated by glucagon-like peptide 1 (GLP-1).
L'invention concerne des polypeptides, des compositions et des méthodes utiles pour activer un récepteur de peptide-1 de type glucagon (GLP-1) et traiter ou prévenir des maladies ou des troubles au moins partiellement médiés par le peptide 1 de type glucagon (GLP-1).</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyrEKwjAQANAuDqL-w4FzoUYorkdyJoE0Cdc04lSKxEm0UP8fHfwAp7e8dZW0i_UBmCTFFBhQB2_71IPBbL0G20UOmRREg9yhDC5oK9EBegWKBw2KnM3EV_jGSJws9dtqdZ8eS9n93FT7MyVp6jK_xrLM0608y3u8BNEIIdq2aU8ojv-tD_lGMT0</recordid><startdate>20221222</startdate><enddate>20221222</enddate><creator>GRIBKOFF, Valentin</creator><creator>DILLER, David</creator><creator>SWANSON, Jon</creator><creator>SHRIER, Allison</creator><creator>PENTELUTE, Bradley</creator><creator>SAWYER, Jonathon</creator><creator>GUNASEKERA, Dinara</creator><creator>SAWYER, Tomi</creator><creator>AUDIE, Joseph</creator><creator>SANTIAGO, Solimar</creator><scope>EVB</scope></search><sort><creationdate>20221222</creationdate><title>GLP-1 RECEPTOR AGONISTS HAVING IMPROVED PHARMACOLOGICAL AND DRUG DELIVERY PROPERTIES</title><author>GRIBKOFF, Valentin ; DILLER, David ; SWANSON, Jon ; SHRIER, Allison ; PENTELUTE, Bradley ; SAWYER, Jonathon ; GUNASEKERA, Dinara ; SAWYER, Tomi ; AUDIE, Joseph ; SANTIAGO, Solimar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2022266068A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><toplevel>online_resources</toplevel><creatorcontrib>GRIBKOFF, Valentin</creatorcontrib><creatorcontrib>DILLER, David</creatorcontrib><creatorcontrib>SWANSON, Jon</creatorcontrib><creatorcontrib>SHRIER, Allison</creatorcontrib><creatorcontrib>PENTELUTE, Bradley</creatorcontrib><creatorcontrib>SAWYER, Jonathon</creatorcontrib><creatorcontrib>GUNASEKERA, Dinara</creatorcontrib><creatorcontrib>SAWYER, Tomi</creatorcontrib><creatorcontrib>AUDIE, Joseph</creatorcontrib><creatorcontrib>SANTIAGO, Solimar</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GRIBKOFF, Valentin</au><au>DILLER, David</au><au>SWANSON, Jon</au><au>SHRIER, Allison</au><au>PENTELUTE, Bradley</au><au>SAWYER, Jonathon</au><au>GUNASEKERA, Dinara</au><au>SAWYER, Tomi</au><au>AUDIE, Joseph</au><au>SANTIAGO, Solimar</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>GLP-1 RECEPTOR AGONISTS HAVING IMPROVED PHARMACOLOGICAL AND DRUG DELIVERY PROPERTIES</title><date>2022-12-22</date><risdate>2022</risdate><abstract>Disclosed are polypeptides, compositions, and methods useful for activating a glucagon-like peptide- 1 (GLP-1) receptor and treating or preventing diseases or disorders at least partially mediated by glucagon-like peptide 1 (GLP-1).
L'invention concerne des polypeptides, des compositions et des méthodes utiles pour activer un récepteur de peptide-1 de type glucagon (GLP-1) et traiter ou prévenir des maladies ou des troubles au moins partiellement médiés par le peptide 1 de type glucagon (GLP-1).</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; fre |
recordid | cdi_epo_espacenet_WO2022266068A2 |
source | esp@cenet |
title | GLP-1 RECEPTOR AGONISTS HAVING IMPROVED PHARMACOLOGICAL AND DRUG DELIVERY PROPERTIES |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T21%3A51%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GRIBKOFF,%20Valentin&rft.date=2022-12-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2022266068A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |